The medicalization and health risk constructions/ expansions on prescribing and pharmaceutical input has greatly shifted the sociological view point of medicine during the late 20th century and into the 21st century. Medicalization has shifted its viewed and changed upon into a commercial and market based consumerism. The definition of what is supposedly viewed upon as “normal” human behaviors has changed over the past decades. The rapid growth of different and new diagnosis due to biotechnology has created an increase in awareness and recognition of disorders. There is a social construction that the new medicalization encompasses and therefore this has created attention and changed views about the advancement in medicine.
The pharmaceutical …show more content…
Diseases such as cystic fibrosis cannot be fixed before birth and gene planning cannot be done. However for characteristics such as obesity and baldness there are pharmaceutical uptakes to put in the market. Obesity has become a large problem in North America and currently there are diet routines that can be used that are prescribed by some physicians. In the future there might be genetic enhancements (also known as biomedical enhancement) that medicalization might turn in to (Conard, 2005). Since there are such options in the market due to pharmaceutical companies, a consumer base opens up for obesity and baldness. The social construct of baldness and the different advertisements that go on televisions, on the internet and on social media sites are what has socially grown into a …show more content…
For example, the HPV vaccines had the gendering risk and the two reasons for this was because of pharmaceutical marketing and targeting and also because of the gender conceptualizations that has socially been brought out into public. Managed care organizations are also a factor that influence medicalization. There are certain treatments that managed care organizations might not be able to cover, and this leads to private markets in order to receive treatments and leads to different drugs to being promoted (Conrad, 2005). These sort of issues such as gendering and managed care organizations influence the medicalization to
The pharmaceutical …show more content…
Diseases such as cystic fibrosis cannot be fixed before birth and gene planning cannot be done. However for characteristics such as obesity and baldness there are pharmaceutical uptakes to put in the market. Obesity has become a large problem in North America and currently there are diet routines that can be used that are prescribed by some physicians. In the future there might be genetic enhancements (also known as biomedical enhancement) that medicalization might turn in to (Conard, 2005). Since there are such options in the market due to pharmaceutical companies, a consumer base opens up for obesity and baldness. The social construct of baldness and the different advertisements that go on televisions, on the internet and on social media sites are what has socially grown into a …show more content…
For example, the HPV vaccines had the gendering risk and the two reasons for this was because of pharmaceutical marketing and targeting and also because of the gender conceptualizations that has socially been brought out into public. Managed care organizations are also a factor that influence medicalization. There are certain treatments that managed care organizations might not be able to cover, and this leads to private markets in order to receive treatments and leads to different drugs to being promoted (Conrad, 2005). These sort of issues such as gendering and managed care organizations influence the medicalization to